277
Participants
Start Date
September 30, 2005
Primary Completion Date
February 28, 2007
Study Completion Date
February 28, 2007
Resatorvid
Resatorvid 1.2 mg/kg, injection, subcutaneously for thirty minutes; then resatorvid 0.05 mg/kg/h (1.2 mg/kg/day), injection, subcutaneously over 96 hours.
Resatorvid
Resatorvid 1.2 mg/kg, injection, subcutaneously for thirty minutes; then resatorvid 0.1 mg/kg/h (2.4 mg/kg/day), injection, subcutaneously over 96 hours.
Placebo
Resatorvid placebo-matching injection, subcutaneously for thirty minutes; then resatorvid placebo-matching injection, subcutaneously over 96 hours.
Birmingham
Mobile
Phoenix
Scottsdale
Escondido
Los Angeles
Orange
Poway
San Diego
Colorado Springs
New Haven
Newark
Atlantis
Bay Pines
Jacksonville
Miami
Orlando
Sarasota
Atlanta
Augusta
Chicago
Peoria
Indianapolis
Des Moines
Louisville
Shreveport
Portland
Baltimore
Springfield
Kalamazoo
Kansas City
St Louis
Butte
Englewood
Buffalo
New York
Rochester
Greensboro
Winston-Salem
Akron
Columbus
Oklahoma City
Greenville
Nashville
Fort Worth
Galveston
Houston
Lubbock
Bellevue
Adelaide
Fremantle
Heidelberg
Linz
Vienna
Aalst
Antwerp
Brussels
Genk
Ghent
Liège
Ottignies
Yvoir
Calgary
Vancouver
Victoria
Winnipeg
Halifax
London
Brno
Havlíčkův Brod
Hradec Králové
Opava
Pilsen
Prague
Helsinki
Joensuu
Kokkola
Kuopio
Lappeenranta
Oulu
Seinäjoki
Tampere
Turku
Berlin
Dresden
Erfurt
Jena
Krefeld
Ludwigshafen
Mannheim
München
Wuppertal
Afula
Ashkelon
Haifa
Holon
Jerusalem
Kfar Saba
Petah Tikva
Ẕerifin
Lecco
Monza
Pavia
Chiba
Fukuoka
Hiroshima
Hokkaido
Kumamoto
Kyoto
Numakunai
Osaka
Shizuoka
Tokyo
Yamaguchi
's-Hertogenbosch
Apeldoorn
Groningen
Leeuwarden
Nijmegen
Rotterdam
Tilburg
Auckland
Christchurch
Hastings
Tauranga
San Juan
Barcelona
Getafe
Madrid
Valladolid
Vitoria-Gasteiz
Gävle
Gothenburg
Karlstad
Kristianstad
Linköping
Lund
Stockholm
Uppsala
Brighton
Glasgow
Leeds
Livingston
London
Lead Sponsor
Takeda
INDUSTRY